Parse Biosciences Analysis: $9M Raised
What is Parse Biosciences?
Scalable single cell sequencing technology
Location
Seattle, United States
Employees
51-200
Founded
2018
Product Features & Capabilities
- Evercode WT Mini
- Evercode WT
- Evercode WT Mega
- Evercode WT Penta
- Evercode TCR
- Evercode BCR
- Evercode Fixation
- Gene Select
- CRISPR Detect
Other Considerations
Acquired by QIAGEN in 2025; Serves over 3,000 laboratories globally; Recognized for high data quality in single cell sequencing; Partnerships with various research institutions
